Cite
HARVARD Citation
Hassanein, M. et al. (2019). Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial. Diabetes research and clinical practice. pp. 331-341. [Online].